Corvus Pharmaceuticals Earning Date (CRVS)

USA |NASDAQ |USD

CRVS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Oct 31, 2022 Sep 2022 $-0.23 - $-0.24
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Oct 31, 2022 Sep 2022 $0.00 - $0.00

Corvus Pharmaceuticals's next earnings date is Monday, Oct 31, 2022 for the fiscal quarter ending Sep 2022.

CRVS Earnings Date & History Chart

CRVS Earnings & Revenue Forecast

CRVS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 3 $-0.23 $-0.26 $-0.20
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $-0.84 $-0.96 $-0.75
Dec 2023 3 $-1.08 $-1.58 $-0.77

CRVS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Sep 2022 0 / 0 $-0.23 $-0.23 $-0.22
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.84 $-0.84 $-0.81
Dec 2023 0 / 0 $-1.08 $-1.03 $-1.04

CRVS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Sep 2022 3 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $0.00 $0.00 $0.00
Dec 2023 3 $0.00 $0.00 $0.00

CRVS Earnings Date & Revenue History

CRVS Earnings History

|
Show More
Show More

CRVS Revenue History

|
Show More
Show More

Corvus Pharmaceuticals Next Earnings Date & Report

CRVS Next Earnings Date & Report Preview: Sep 2022 (FQ)

CRVS's next earnings date is Monday, Oct 31, 2022 for the fiscal quarter ending Sep 30, 2022.

According to analysts, the average EPS estimation for Corvus Pharmaceuticals's next quarterly earnings is $-0.23, with a low EPS estimation of $-0.26, and a high estimation of $-0.20.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.23, the last 2 month trend is $-0.23, and the 3 month trend is $-0.22.

Based on analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Corvus Pharmaceuticals Previous Earnings Dates & Reports

CRVS Previous Earnings Date & Report Recap: Jun 2022 (FQ)

Corvus Pharmaceuticals's previous earnings date was Aug 1, 2022 for its fiscal quarter ended Jun 30, 2022.

CRVS Previous Earnings Date & Report Recap: Dec 2021 (FY)

Corvus Pharmaceuticals's previous annual earnings date was Mar 10, 2022 for its fiscal year ended Dec 31, 2021.

CRVS's earnings per share (EPS) was $-1.06, missing the consensus analysts forecast of $-1.00 by 6.00% , and higher than the previous year's EPS (Dec 2020) by -27.93%.

Revenues were $0.00.

The company reported a net income of $-43.24M.

Corvus Pharmaceuticals reported a free cash flow of $-36.72M for its fiscal year, compared to $-34.85M a year ago.

The company ended the fiscal year with $3.65M in total debt, an increase of 57.88% compared to the previous year.